Abstract
Unlabelled
B cells often constitute abundant cellular components in human tumors. Regulatory B cells that are functionally defined by their ability to produce IL10 downregulate inflammation and control T-cell immunity. Here, we identified a protumorigenic subset of B cells that constitutively expressed higher levels of programmed cell death-1 (PD-1) and constituted ∼10% of all B cells in advanced-stage hepatocellular carcinoma (HCC). These PD-1(hi) B cells exhibited a unique CD5(hi)CD24(-/+)CD27(hi/+)CD38(dim) phenotype different from the phenotype of conventional CD24(hi)CD38(hi) peripheral regulatory B cells. TLR4-mediated BCL6 upregulation was crucial for PD-1(hi) B-cell induction by HCC environmental factors, and that effect was abolished by IL4-elicited STAT6 phosphorylation. Importantly, upon encountering PD-L1(+) cells or undergoing PD-1 triggering, PD-1(hi) B cells acquired regulatory functions that suppressed tumor-specific T-cell immunity and promoted cancer growth via IL10 signals. Our findings provide significant new insights for human cancer immunosuppression and anticancer therapies regarding PD-1/PD-L1.Significance
We identify a novel protumorigenic PD-1(hi) B-cell subset in human HCC that exhibits a phenotype distinct from that of peripheral regulatory B cells. TLR4-mediated BCL6 upregulation is critical for induction of PD-1(hi) B cells, which operate via IL10-dependent pathways upon interacting with PD-L1 to cause T-cell dysfunction and foster disease progression. Cancer Discov; 6(5); 546-59. ©2016 AACR.See related commentary by Ren et al., p. 477This article is highlighted in the In This Issue feature, p. 461.Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment.
Nat Rev Cancer, 24 Oct 2024
Cited by: 0 articles | PMID: 39448877
Review
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.
Cancer Immunol Immunother, 73(12):252, 03 Oct 2024
Cited by: 0 articles | PMID: 39358617 | PMCID: PMC11447174
Spatial single-cell protein landscape reveals vimentin<sup>high</sup> macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma.
Nat Cancer, 5(10):1557-1578, 26 Sep 2024
Cited by: 0 articles | PMID: 39327501
Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients.
World J Hepatol, 16(10):1158-1168, 01 Oct 2024
Cited by: 0 articles | PMID: 39474576 | PMCID: PMC11514615
Review Free full text in Europe PMC
The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).
Oxf Open Immunol, 5(1):iqae012, 20 Sep 2024
Cited by: 0 articles | PMID: 39346706 | PMCID: PMC11427547
Review Free full text in Europe PMC
Go to all (178) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Funding
Funders who supported this work.
Doctoral Dissertation of PR China (1)
Grant ID: 201230
Fundamental Research Funds for the Central Universities (1)
Grant ID: 15lgjc09
Guangdong Natural Science Funds for Distinguished Young Scholars (1)
Grant ID: S2013050014639
National Natural Science Foundation of China (3)
Grant ID: 81171982
Grant ID: 31470855
Grant ID: 81422036